Cargando…

The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients

BACKGROUND: Sarcoidosis and tuberculosis (TB) are two granulomatous inflammatory diseases with several common symptoms. The aim of the present study was to compare the serum levels of biomarkers including interleukin-4 (IL-4) and IL-13, calcium (Ca), hemoglobin, sedimentation rate, and lymphocyte-to...

Descripción completa

Detalles Bibliográficos
Autores principales: Abedini, Atefeh, Naderi, Zohre, Kiani, Arda, Marjani, Majid, Mortaz, Esmaeil, Ghorbani, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213005/
https://www.ncbi.nlm.nih.gov/pubmed/32419781
http://dx.doi.org/10.4103/jrms.JRMS_74_19
_version_ 1783531716461199360
author Abedini, Atefeh
Naderi, Zohre
Kiani, Arda
Marjani, Majid
Mortaz, Esmaeil
Ghorbani, Fariba
author_facet Abedini, Atefeh
Naderi, Zohre
Kiani, Arda
Marjani, Majid
Mortaz, Esmaeil
Ghorbani, Fariba
author_sort Abedini, Atefeh
collection PubMed
description BACKGROUND: Sarcoidosis and tuberculosis (TB) are two granulomatous inflammatory diseases with several common symptoms. The aim of the present study was to compare the serum levels of biomarkers including interleukin-4 (IL-4) and IL-13, calcium (Ca), hemoglobin, sedimentation rate, and lymphocyte-to-neutrophil ratio between patients with pulmonary TB, patients with sarcoidosis, and control group. MATERIALS AND METHODS: This case–control study was performed on patients referred to the Masih Daneshvari Hospital, Tehran, from April 2017 to 2018. In this study, 24 newly diagnosed patients with active pulmonary TB, 34 patients with pulmonary sarcoidosis, and 30 healthy individuals as the control group were enrolled. Demographic data, erythrocyte sedimentation rate (ESR), the ratio of neutrophil-to-lymphocyte (NLR), serum Ca level, hemoglobin (Hb), and IL-4 and IL-13 were compared between the study groups. Receiver operating characteristic (ROC) curve analysis, sensitivity, and specificity were also calculated using SPSS 16.0 software. RESULTS: The mean age was 47.71 ± 10.88 and 55.25 ± 21.58 years in the sarcoidosis and TB. The mean ESR in sarcoidosis patients was 21.45 ± 13.37 mm/h and 41.4 ± 17 mm/h in the TB group. The percentage of peripheral blood lymphocytes in sarcoidosis and TB patients was 28.02 ± 12.20 and 21.41 ± 12.49, respectively, which was significantly higher among patients with sarcoidosis. NLR was also 2.4 ± 1.6 and 4.4 ± 2.9 in sarcoidosis and TB patients, respectively, which showed a significant difference among the groups. Regarding the evaluation of the level of IL-4 and IL-13 in patients, it is worth noting that IL-4 in patients with sarcoidosis was 90 pg/ml compared to 20 pg/ml for TB patients (P < 0.001). There was no significant difference in the levels of IL-13 in the TB and control groups, which varied between 20 and 80 pg/ml (P = 0.35). However, its value was significantly higher in patients with sarcoidosis (P = 0.01) than in the healthy control group and TB (P = 0.01). The ROC curves showed that the diagnostic cutoff of ESR level, Ca, NLR, and Hb could be valuable due to the area under the curves. The cutpoint of 34 mm/h for ESR had a sensitivity of 86% as well as 80% specificity to distinguish TB from the sarcoidosis. CONCLUSION: Serum levels of the biomarkers indicated a stronger immunological background in sarcoidosis using NLR, Ca, ESR, and Hb.
format Online
Article
Text
id pubmed-7213005
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-72130052020-05-15 The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients Abedini, Atefeh Naderi, Zohre Kiani, Arda Marjani, Majid Mortaz, Esmaeil Ghorbani, Fariba J Res Med Sci Original Article BACKGROUND: Sarcoidosis and tuberculosis (TB) are two granulomatous inflammatory diseases with several common symptoms. The aim of the present study was to compare the serum levels of biomarkers including interleukin-4 (IL-4) and IL-13, calcium (Ca), hemoglobin, sedimentation rate, and lymphocyte-to-neutrophil ratio between patients with pulmonary TB, patients with sarcoidosis, and control group. MATERIALS AND METHODS: This case–control study was performed on patients referred to the Masih Daneshvari Hospital, Tehran, from April 2017 to 2018. In this study, 24 newly diagnosed patients with active pulmonary TB, 34 patients with pulmonary sarcoidosis, and 30 healthy individuals as the control group were enrolled. Demographic data, erythrocyte sedimentation rate (ESR), the ratio of neutrophil-to-lymphocyte (NLR), serum Ca level, hemoglobin (Hb), and IL-4 and IL-13 were compared between the study groups. Receiver operating characteristic (ROC) curve analysis, sensitivity, and specificity were also calculated using SPSS 16.0 software. RESULTS: The mean age was 47.71 ± 10.88 and 55.25 ± 21.58 years in the sarcoidosis and TB. The mean ESR in sarcoidosis patients was 21.45 ± 13.37 mm/h and 41.4 ± 17 mm/h in the TB group. The percentage of peripheral blood lymphocytes in sarcoidosis and TB patients was 28.02 ± 12.20 and 21.41 ± 12.49, respectively, which was significantly higher among patients with sarcoidosis. NLR was also 2.4 ± 1.6 and 4.4 ± 2.9 in sarcoidosis and TB patients, respectively, which showed a significant difference among the groups. Regarding the evaluation of the level of IL-4 and IL-13 in patients, it is worth noting that IL-4 in patients with sarcoidosis was 90 pg/ml compared to 20 pg/ml for TB patients (P < 0.001). There was no significant difference in the levels of IL-13 in the TB and control groups, which varied between 20 and 80 pg/ml (P = 0.35). However, its value was significantly higher in patients with sarcoidosis (P = 0.01) than in the healthy control group and TB (P = 0.01). The ROC curves showed that the diagnostic cutoff of ESR level, Ca, NLR, and Hb could be valuable due to the area under the curves. The cutpoint of 34 mm/h for ESR had a sensitivity of 86% as well as 80% specificity to distinguish TB from the sarcoidosis. CONCLUSION: Serum levels of the biomarkers indicated a stronger immunological background in sarcoidosis using NLR, Ca, ESR, and Hb. Wolters Kluwer - Medknow 2020-03-18 /pmc/articles/PMC7213005/ /pubmed/32419781 http://dx.doi.org/10.4103/jrms.JRMS_74_19 Text en Copyright: © 2020 Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Abedini, Atefeh
Naderi, Zohre
Kiani, Arda
Marjani, Majid
Mortaz, Esmaeil
Ghorbani, Fariba
The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title_full The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title_fullStr The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title_full_unstemmed The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title_short The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
title_sort evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213005/
https://www.ncbi.nlm.nih.gov/pubmed/32419781
http://dx.doi.org/10.4103/jrms.JRMS_74_19
work_keys_str_mv AT abediniatefeh theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT naderizohre theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT kianiarda theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT marjanimajid theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT mortazesmaeil theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT ghorbanifariba theevaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT abediniatefeh evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT naderizohre evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT kianiarda evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT marjanimajid evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT mortazesmaeil evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients
AT ghorbanifariba evaluationofinterleukin4andinterleukin13intheserumofpulmonarysarcoidosisandtuberculosispatients